| Customization: | Available |
|---|---|
| Type: | Surgical Supplies Materials |
| Material: | Cytocare 532 |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Product Description
CYTOCARE 532 (5x5ml) REVITACARE
For medical use only. Sterile single use medical devices class III.
DESCRIPTION
CYTOCARE 532 is a range of resorbable implant composed of Hyaluronic acid + Rejuvenating complex, injectable by micro-injections into super cial dermis of the face to
treat: ne lines and wrinkles, dehydrated skin and lack of density and radiance of the skin.
Complex combined CT50 rejuvenating formula and hyaluronic acid 32 mg.
PREVENTION Wrinkle reduction.
Intense re-densi cation and dermal regeneration. Warns against premature aging.
Delays the appearance of wrinkles. High Hydration, glow and radiance.
COMPOSITION CYTOCARE 532 (5x5ml) REVITACARE
Hyaluronic Acid 32 mg.
Uncrosslinked HA of biotechnological origin.
Rejuvenating Complex CT50.
ACTIVE INGREDIENTS
Hyaluronic acid, microelement and multivitamin complex, all 20 essential amino acids, thymidine, putrescine, lipoic acid.
INDICATIONS
Prevention of photoaging.
Stress-induced tired skin appearance.
As preparation for chemical peels, or laser skin resurfacing.
Need for instant short-term improvement in appearance.
INJECTION AREA
Middle dermis or super cial dermis of the face or the neck.
*Do not inject into eyes circles, glabella wrinkles & lips.
CHARACTERISTICS
5 vials x 5ml
Sterilization: aseptic ltration.
Pyrogen free.
Ready to use.
Conservation condition: 2°C to 30°C
Close to neutral pH.
Iso-osmolar solution.
INJECTION METHODS
Manual or gun.
MECHANISM OF ACTION
Amino acids and trace elements activate the regeneration of tissues and restore the epidermal barr ier.
Vitamins provide antioxidant activity and protection for the skin.
Stimulates angiogenesis (the formation of new blood vessels).
CLINICAL RESULTS
The skin gets a refreshed, rested appearance, begins to radiate health from the inside.
PROTOCOL
3 sessions with 3 weeks intervals, then maintenance of the results by 1 session every 3 months.
Protocol and concentration can be adapted depending on the maturity of the skin.
INJECTIONS DEPTH
Middle dermis or super cial dermis of the face or the neck.
INGREDIENTS
Ammonium Molybdate, Ammonium Metavanadate, Calcium Chloride, Iron Sulfate,Copper Sulfate, Magnesium Chloride, Manganese Sulfate, Sodium
Acetate, Sodium Hydrogen Carbonate, Sodium Chloride, Sodium Hydrogen Phosphate, Sodium Metasilicate, Sodium Selenite, Nickel Chloride, Tin Chloride, Zinc Sulfate,
Alanine, Arginine, Asparagine, Aspartic Acid, Cysteine, Glutamine, Glutamic Acid, Glycine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Proline, Serine,
Threonine, Tryptophan, Tyrosine, Valine, Adenine (Vit.B4), Biotin (Vit.B8), Calcium Pantothenate(Vit.B5), Choline Chloride, Folic Acid (Vit.B9), Inositol (Vit.B7), Nicotinamide
(Vit.B3), Pyridoxine (Vit.B6), Ribo¡avin (Vit.B2), Thiamine (Vit.B1), Vitamin B12, Deoxythymidine, Glucose, Putrescine, Sodium Pyruvate, Lipoic Acid.
GAMME CYTOCARE BY REVITACARE
To reduce appearance of ne lines and wrinkles, to hydrate & improve skin tone and redensify skin.
Case: 5 vials x 5 ml or 10 vials x 5 ml
CYTOCARE 502: Young skin 25 to 35 years old
CYTOCARE 516: Medium skin 35 to 50 years old
CYTOCARE 532: Mature skin 50 years old and more.
CYTOCARE is a range of resorbable implant composed of Hyaluronic acid + Rejuvenating complex, injectable by micro-injections into super cial dermis of face, neck, back
of hands.
CYTOCARE 502, CYTOCARE 516, CYTOCARE 532 are sterile single use medical devices class III.
Indicated for the prevention and attenuation of wrinkles and ne lines, and for the hydration of the epidermis of the face, neck and back of the hands. For medical use only.
COMPOSITION
Hyaluronic Acid 2 mg - 16 mg - 32 mg.
Non cross-linked biotechnological origin.
Rejuvenating Complex CT50.
CARACTERISTICS
QUALITY . SECURITY . EFFICIENCY.
Related Products:
){kind=link}